State Board of Administration of Florida Retirement System lowered its position in Halyard Health Inc. (NYSE:HYH) by 4.3% during the second quarter, Holdings Channel reports. The firm owned 29,367 shares of the company’s stock after selling 1,322 shares during the period. State Board of Administration of Florida Retirement System owned approximately 0.06% of Halyard Health worth $955,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Norges Bank acquired a new stake in Halyard Health during the fourth quarter worth about $38,025,000. Chicago Equity Partners LLC bought a new position in Halyard Health during the second quarter worth $7,189,000. Emerald Acquisition Ltd. bought a new position in Halyard Health during the second quarter worth $4,905,000. Bogle Investment Management L P DE bought a new position in Halyard Health during the first quarter worth $1,456,000. Finally, Credit Agricole S A boosted its position in Halyard Health by 137.7% in the first quarter. Credit Agricole S A now owns 57,038 shares of the company’s stock worth $1,639,000 after buying an additional 33,038 shares in the last quarter. 82.94% of the stock is owned by hedge funds and other institutional investors.
Halyard Health Inc. (NYSE:HYH) traded down 2.64% during trading on Friday, hitting $33.96. The stock had a trading volume of 287,937 shares. The company’s 50-day moving average is $35.81 and its 200 day moving average is $32.20. The firm’s market cap is $1.59 billion. Halyard Health Inc. has a 52 week low of $22.76 and a 52 week high of $37.31.
Halyard Health (NYSE:HYH) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported $0.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.09. The company had revenue of $400 million for the quarter, compared to the consensus estimate of $383.08 million. Halyard Health had a positive return on equity of 8.91% and a negative net margin of 27.63%. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.52 EPS. Equities analysts expect that Halyard Health Inc. will post $1.82 EPS for the current fiscal year.
HYH has been the subject of a number of analyst reports. Deutsche Bank AG upped their price target on Halyard Health from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Wednesday, August 10th. Stifel Nicolaus upped their price target on Halyard Health from $32.00 to $37.00 and gave the stock a “buy” rating in a report on Tuesday, June 14th. Finally, TheStreet upgraded Halyard Health from a “sell” rating to a “hold” rating in a report on Friday, July 8th. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $34.20.
Halyard Health Company Profile
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health Inc. (NYSE:HYH).
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.